SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:umu-142067"
 

Search: id:"swepub:oai:DiVA.org:umu-142067" > The clinical course...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

The clinical course after glucocorticoid treatment in patients with inflammatory bowel disease is linked to suppression of the hypothalamic-pituitary-adrenal axis : a retrospective observational study

Ibrahim, Aghil (author)
Umeå universitet,Medicin
Dahlqvist, Per (author)
Umeå universitet,Medicin
Olsson, Tommy (author)
Umeå universitet,Medicin
show more...
Lundgren, David (author)
Umeå universitet,Medicin
Werner, Mårten (author)
Umeå universitet,Medicin
Suhr, Ole B. (author)
Umeå universitet,Medicin
Karling, Pontus (author)
Umeå universitet,Medicin
show less...
 (creator_code:org_t)
London : Sage Publications, 2017
2017
English.
In: Therapeutic Advances in Gastroenterology. - London : Sage Publications. - 1756-283X .- 1756-2848. ; 10:11, s. 829-836
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: Adrenal insufficiency (AI) secondary to treatment with glucocorticoids (GCs) is common in patients with inflammatory bowel disease (IBD), but little is known about the relationship between AI and the clinical course in IBD. The aim of the study was to compare the clinical course in IBD patients with normal adrenal function versus patients with subnormal adrenal function.Methods: A retrospective observational study on 63 patients with IBD who had performed a low-dose short Synacthen test (LDSST) (1 μg) immediately (1-7 days) after a standard course of GCs. A subnormal LDSST was defined as serum cortisol <550 nmol/L. Outcomes were time to next flare and fecal calprotectin levels.Results: Sixty-three percent (n = 40) of the IBD patients had a subnormal LDSST. Patients who were steroid-free (n = 41) after the LDSST were observed for 3 years. Patients with a peak serum cortisol <400 nmol/L immediately after GC treatment had significantly longer time until the next flare-up of their IBD and tended to use a lower cumulative prednisolone dose during the study period in comparison to the other subgroups. Fecal calprotectin levels were significantly lower in patients with a peak s-cortisol <550 nmol/L versus patients with peak s-cortisol ⩾550 nmol/L (median 336 µg/g (IQR 521) versus 955 µg/g (IQR 1867); p = 0.012).Conclusions: GC-induced AI is common in patients with IBD and is associated with lower disease activity. This suggests a link between responsiveness to GC treatment and suppression of the hypothalamic-pituitary-adrenal axis in IBD.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Gastroenterologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)

Keyword

Crohn’s disease
adrenal insufficiency
clinical pharmacology
immunosuppression
inflammatory bowel disease
ulcerative colitis

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view